See more : Bergman & Beving AB (publ) (BERG-B.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Branded Legacy Inc (BLEG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Branded Legacy Inc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Lotus Eye Hospital and Institute Limited (LEHIL.BO) Income Statement Analysis – Financial Results
- Lån & Spar Invest – Danske Aktier Basis Akkumulerende (LSIDBA.CO) Income Statement Analysis – Financial Results
- Anheuser-Busch InBev SA/NV (BUDFF) Income Statement Analysis – Financial Results
- Hidili Industry International Development Limited (HIIDQ) Income Statement Analysis – Financial Results
- Ya-Man Ltd. (6630.T) Income Statement Analysis – Financial Results
Branded Legacy Inc (BLEG)
About Branded Legacy Inc
Branded Legacy Inc engages in the commercial development of hemp and cannabinoid-infused beverages in Central Florida. It provides CBD topicals and tinctures, and hemp coffees and teas. The company was formerly known as Elev8 Brands, Inc. and changed its name to Branded Legacy Inc in May 2020. Branded Legacy Inc is headquartered in Longwood, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82.91K | 215.53K | 64.26K | 100.63K | 604.50K | 372.31K | 144.76K | 191.00 | 16.90K |
| Cost of Revenue | 265.00 | 72.62K | 33.19K | 77.98K | 236.61K | 159.46K | 69.29K | 0.00 | 8.24K |
| Gross Profit | 82.64K | 142.91K | 31.07K | 22.65K | 367.89K | 212.84K | 75.47K | 191.00 | 8.66K |
| Gross Profit Ratio | 99.68% | 66.31% | 48.35% | 22.51% | 60.86% | 57.17% | 52.14% | 100.00% | 51.25% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 252.29K | 244.12K | 682.19K | 477.53K | 158.24K | 364.00 | 76.48K |
| Selling & Marketing | 0.00 | 0.00 | 92.59K | 76.99K | 136.74K | 103.13K | 42.70K | 0.00 | 0.00 |
| SG&A | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -30.00 | -171.00 |
| Operating Expenses | -3.74M | 306.61K | 344.87K | 321.11K | 818.92K | 580.66K | 200.93K | 364.00 | 76.48K |
| Cost & Expenses | -3.74M | 379.23K | 378.06K | 399.09K | 1.06M | 740.12K | 270.22K | 364.00 | 84.72K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 20.63K | 236.56K | 3.61K | 3.59K | 3.54K | 52.52K | 22.82K | 250.00 |
| EBITDA | 3.83M | -143.07K | -313.80K | -294.85K | -2.05M | -364.27K | -125.46K | -173.00 | -67.57K |
| EBITDA Ratio | 4,614.24% | -66.39% | -488.37% | -293.01% | -74.61% | -97.84% | -86.67% | -90.58% | -399.80% |
| Operating Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -173.00 | -67.82K |
| Operating Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -90.58% | -401.28% |
| Total Other Income/Expenses | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -72.00 | -369.00 |
| Income Before Tax | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Income Before Tax Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| Income Tax Expense | -167.90K | -5.00 | -236.56K | -1.00 | -1.61M | -157.60K | -52.52K | -22.77K | 198.00 |
| Net Income | 3.83M | -163.70K | -313.80K | -298.46K | -451.03K | -367.82K | -125.46K | -245.00 | -68.19K |
| Net Income Ratio | 4,614.24% | -75.95% | -488.37% | -296.61% | -74.61% | -98.79% | -86.67% | -128.27% | -403.47% |
| EPS | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.26 | -0.07 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | -0.17 | -0.01 | -0.24 | -0.25 | -0.07 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.44M | 1.93M | 2.29M | 0.00 |
| Weighted Avg Shares Out (Dil) | 295.00M | 227.85M | 1.90M | 50.14M | 1.90M | 1.48M | 1.93M | 2.29M | 0.00 |
Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements
Branded Legacy strengthens financial stability with a new line of credit and commits to enhancing shareholder value by avoiding a reverse stock split. MELBOURNE, Fla.
Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow
A Billion Shares Retired: Branded Legacy's Unwavering Commitment to Shareholder Value MELBOURNE, Fla. , Oct. 26, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC.PK: BLEG), proudly announces a significant enhancement to its commitment to bolstering shareholder value.
Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023
Management Team's Pledge to Preserve Shareholder Value and Stability MELBOURNE, Fla. , Oct. 19, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC.PK: BLEG), a holdings company focused on advancing biotechnical research, is pleased to announce a significant milestone in its ongoing...
Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion
Branded Legacy Expands Portfolio and Revenue Outlook with The Alcannabist Acquisition MELBOURNE, Fla. , Oct. 10, 2023 /PRNewswire/ -- Branded Legacy, Inc. (OTC.PK: BLEG), an established player in the biotechnology sector, has completed the acquisition of The Alcannabist LLC.
Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC
Acquisition & more space to revolutionize Alkaloid Research and Natural Medicine offerings to the wellness community MELBOURNE, Fla. , Oct. 3, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC.PK: BLEG), Branded Legacy Inc., a leading name in the biotech industry, takes a...
Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion
MELBOURNE, Fla. , Sept. 26, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC-PINK: BLEG), a prominent player in the biotech industry, proudly announces a substantial investment aimed at expanding its production capabilities and elevating its product offerings.
Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans
Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans MELBOURNE, Fla , Sept. 12, 2023 /PRNewswire/ -- Branded Legacy, Inc (OTC.PK: BLEG), an emerging biotechnology company, is excited to announce a strategic partnership with Novus Acquisition &...
Branded Legacy, Inc. Successfully Completes Acquisition of Rocket Web Development and Design
MELBOURNE, Fla., Aug. 15, 2023 /PRNewswire/ -- Branded Legacy, a holdings company focused on biotechnology, is pleased to announce that it has completed the acquisition of Rocket Web Development and Design (RWDD). This significant milestone underscores Branded Legacy's commitment to...
Branded Legacy, Inc. Unveils Strategic Transformation in Investor Teleconference
MELBOURNE, Fla. , July 27, 2023 /PRNewswire/ -- Branded Legacy, Inc.
Branded Legacy, Inc. Signs Letter of Intent to Acquire a Mycology Research Lab
Company Executes Immediate Action Plan MELBOURNE, Fla. , July 18, 2023 /PRNewswire/ -- Branded Legacy, Inc. (OTC-PINK: BLEG), a holding company specializing in growth through acquisitions with a focus on the Biotechnology sector, announced today that is has a signed...
Source: https://incomestatements.info
Category: Stock Reports